申请人:Mitchell Jason Darren
公开号:US20080027065A1
公开(公告)日:2008-01-31
The invention relates to compounds of formula (I)
processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the GPR38 receptor.
本发明涉及式(I)化合物,其制备方法,含有它们的制药组合物以及它们在治疗通过GPR38受体介导的疾病或疾病中的应用。